Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiomics-Based Visualization and Quantitative Validation of Isocitrate Dehydrogenase 1 Heterogeneity in Gliomas

NCT05969691 is registered in ClinicalTrials.gov with Mingge LLC as lead sponsor.

NCT NCT05969691
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05969691 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiomics-Based Visualization and Quantitative Validation of Isocitrate Dehydrogenase 1 Heterogeneity in Gliomas
Lead sponsor
Mingge LLC
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 15, 2019
Completion date
December 15, 2026
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

computer-assisted, glioma, malignant